Commercialization and collaboration: Competing policies in publicly funded stem cell research?

Cell Stem Cell

Volumn 7, Issue 1, 2010, Pages 25-30

  Bubela, Tania ^a   Strotmann, Andreas ^a   Adams, Rhiannon ^a   Morrison, Shawn ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Dryas Research Ltd   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIBLIOMETRICS; COMMERCIAL PHENOMENA; COMMERCIALIZATION; FUNDING; HEALTH CARE POLICY; HUMAN; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; STEM CELL RESEARCH; CANADA; ECONOMICS; ETHICS; LEGAL ASPECT; MEDICAL RESEARCH; STEM CELL;

BIOMEDICAL RESEARCH; CANADA; STEM CELLS;

EID: 77957679836     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2010.06.010     Document Type: Article

References (19)

1. Atkinson-Grosjean, A. (2005). Public Science Private Interests: Culture and Commerce in Canada's Networks of Centres of Excellence (Toronto: University of Toronto Press).
2. Bergman, K., and Graff, G.D. (2007). Nat. Biotechnol. 25, 419-424.
3. Caulfield, T., Ogbogu, U., Murdoch, C., and Einsiedel, E. (2008). Regen. Med. 3, 483-496.
4. Edwards, A.M., Bountra, C., Kerr, D.J., and Willson, T.M. (2009). Nat. Chem. Biol. 5, 436-440.
5. Giebel, L.B. (2005). Nat. Biotechnol. 23, 798-800.
6. Gold, E.R., Adams, W., Bernier, L., Bubela, T., Cassivi, L., Castle, D., Cleret de Langavant, G., Cloutier, L.M., Daar, A.S., Delerue, H., et al. (2008) online: The Innovation Partnership (http://www.theinnovationpartnership.org/en/ ieg/report/).
7. Herder, M., and Brian, J.D. (2008). J. Bus. Ethics 77, 73-84.
8. Hong, W., and Walsh, J.P. (2009). Sociological Quarterly 50, 145-171.
9. Huang, K.G., and Murray, F.R. (2009). Acad. Manage. J. 52, 1193-1221.
10. Katz, J.S., and Martin, B.R. (1997). Res. Policy 26, 1-18.
11. Lee, S.S., and Bozeman, B. (2005). Social Studies of Science 35, 673-702.
12. Little, M., Hall, W., and Orlandi, A. (2006). EMBO Rep. 7, 1188-1192.
13. Moed, H.F. (2005). Citation Analysis in Research Evaluation (Dordrecht, The Netherlands: Springer).
14. Munos, B. (2009). Nat. Rev. Drug Discov. 8, 959-968.
15. Plagnol, A.C., Rowley, E., Martin, P., and Livesay, F. (2009). Future Medicine 4, 549-559.
16. Schofield, P.N., Bubela, T., Weaver, T., Portilla, L., Brown, S.D., Hancock, J.M., Einhorn, D., Tocchini- Valentini, G., Hrabe de Angelis, M., and Rosenthal, N. (2009). Nature 461, 171-173.
17. Strandbourg, K.J., Csardi, G., Tabochnik, J., Erdi, P., and Zalanyi, L. (2006). Berkeley Technol. Law J. 21, 1293-1362.
18. Walsh, J.P., Cho, C., and Cohen, W.M. (2005). Science 309, 2002-2003.
19. Winickoff, D.E., Saha, K., and Graff, G.D. (2009). Yale J. Health Policy Law Ethics 9, 54-126.